Ileal neuroendocrine tumor G1
MONDO:0006250A well differentiated, low grade neuroendocrine tumor (carcinoid tumor) that arises from the ileum. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent.
Also known as: carcinoid tumor of ileum, carcinoid tumor of the ileum, carcinoid tumour of ileum, carcinoid tumour of the ileum, grade 1 neuroendocrine neoplasm of ileum, ileal NET G1, ileal carcinoid tumor, ileal carcinoid tumour
1498 clinical trials for this condition and its sub-types, 3 tagged with Ileal neuroendocrine tumor G1 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New pill aims to tame flushing and diarrhea in rare cancer syndrome
Symptom relief Recruiting nowThis Phase 3 trial tests whether the experimental drug paltusotine can reduce flushing and diarrhea in adults with carcinoid syndrome caused by neuroendocrine tumors. About 141 participants will receive either paltusotine or a placebo daily for 12 weeks. The study measures how mu…
Phase 3 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Virtual reality goggles could be new tool against cancer pain
Symptom relief Recruiting nowThis study tests whether using virtual reality (VR) can reduce severe belly pain and improve quality of life in people with digestive tract cancers. 360 participants will be split into three groups: one using a skills-based VR program, one using distracting VR videos, and a contr…
Sponsor: Cedars-Sinai Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC